No clear answer
Pregabalin: improve symptoms or function in MS (type not specified)
MS (type not specified) · Pain, mood, cognition and other symptoms
Trials have tried this, but none was a controlled phase 2 or 3 trial with a readable result.
- Trials
- 2
- Running now
- 0
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
No controlled trial has reported a result yet.
Other linked trials: 2
Dose comparisons, trials against another medicine, add-on trials, phase 1 and uncontrolled studies. They are listed below but do not set the status.
Trials
Other linked trials: 2
These linked trials do not set the status.
- An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic PainNo result found
Phase 3 · 2010 · Not randomised
- Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic PainNo result found
Phase 3 · 2006 · Not randomised
The deciding phase and counts come from the Trial Bank’s fixed rules.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- 2026-10-27First listed as No clear answer
Related hypotheses
- Pain, mood, cognition and other symptoms: improve symptoms or function in MS (type not specified)
- Donepezil: improve symptoms or function in MS (type not specified)
- Duloxetine: improve symptoms or function in MS (type not specified)
- Escitalopram: improve symptoms or function in MS (type not specified)
- Gabapentin: improve symptoms or function in MS (type not specified)
- Ketamine: improve symptoms or function in MS (type not specified)
- Lidocaine: improve symptoms or function in MS (type not specified)
- Rivastigmine: improve symptoms or function in MS (type not specified)
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error